Evidence map›Paper›PMID 42286243›Full record

ArticleNPJ digital medicine2026

ActiTect: a generalizable machine learning pipeline for REM sleep behavior disorder screening through standardized actigraphy.

David Bertram, Anja Ophey, Sinah Röttgen, Konstantin Kufer, Nele Merten, Gereon R Fink, Elke Kalbe, Clint Hansen, Walter Maetzler, Maximilian Kapsecker and 12 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

David BertramFaculty of Mathematics and Natural Sciences, University of Cologne, Cologne, Germany. dbertram@uni-koeln.de.
Anja OpheyMedical Psychology | Neuropsychology and Gender Studies, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Sinah RöttgenCognitive Neuroscience, Insitute for Neuroscience and Medicine, INM-3, Research Center Juelich, Juelich, Germany.
Konstantin KuferCenter of Neurology, Department of Parkinson, Sleep and Movement Disorders, University Hospital Bonn, University of Bonn, Bonn, Germany.
Nele MertenDepartment of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Gereon R FinkCognitive Neuroscience, Insitute for Neuroscience and Medicine, INM-3, Research Center Juelich, Juelich, Germany.
Elke KalbeMedical Psychology | Neuropsychology and Gender Studies, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Clint HansenDepartment of Neurology, University Medical Center Schleswig-Holstein, Campus Kiel and Kiel University, Kiel, Germany.
Walter MaetzlerDepartment of Neurology, University Medical Center Schleswig-Holstein, Campus Kiel and Kiel University, Kiel, Germany.
Maximilian KapseckerDepartment of Informatics, Technical University of Munich, Munich, Germany.
Lara M ReimerInstitute for Digital Medicine, University Hospital Bonn, Bonn, Germany.
Stephan JonasInstitute for Digital Medicine, University Hospital Bonn, Bonn, Germany.
Andreas T DamgaardLundbeck Foundation Parkinson's Disease Research Center (PACE), Aarhus University, Aarhus, Denmark.
Natasha B BertelsenLundbeck Foundation Parkinson's Disease Research Center (PACE), Aarhus University, Aarhus, Denmark.
Casper SkjaerbaekLundbeck Foundation Parkinson's Disease Research Center (PACE), Aarhus University, Aarhus, Denmark.
Per BorghammerLundbeck Foundation Parkinson's Disease Research Center (PACE), Aarhus University, Aarhus, Denmark.
Karolien GroenewaldOxford Parkinson's Disease Centre and Division of Neurology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Pietro-Luca RattiOxford Parkinson's Disease Centre and Division of Neurology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Michele T HuOxford Parkinson's Disease Centre and Division of Neurology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Noémie MoreauInstitute for Biomedical Informatics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Michael Sommerauer *Cognitive Neuroscience, Insitute for Neuroscience and Medicine, INM-3, Research Center Juelich, Juelich, Germany. michael.sommerauer@ukbonn.de.
Katarzyna Bozek *Institute for Biomedical Informatics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. k.bozek@uni-koeln.de.

Funding

BMBF program for Female Junior Researchers in Artificial Intelligence 01IS20054Deutsche Forschungsgemeinschaft 386793560Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) SFB 1451 (Project-ID 431549029)European Research Council ID 10116958Federal Ministry of Research, Technology and Space (BMFTR), Germany Grant No. 01ZZ2022Koeln Fortune Program, Faculty of Medicine, University of Cologne grant nos. 142/2023, 145/2024, 15/2025"Netzwerke 2021", an initiative of the Ministry of Culture and Science of the State of Northrhine Westphalia, the Federal Ministry of Research, Technology and Space (BMFTR) (FKZ) 01EO2107North Rhine-Westphalia return program 311-8.03.03.02-147635umbrella of the Partnership Fostering a European Research Area for Health (ERA4Health) GA N° 101095426 of the EU Horizon Europe Research and Innovation Programme
6 · The paper itself

Abstract

Isolated rapid eye movement sleep behavior disorder (iRBD) is a major prodromal marker of α-synucleinopathies, often preceding the clinical onset of Parkinson's disease, dementia with Lewy bodies, or multiple system atrophy. While wrist-worn actimeters hold significant potential for detecting RBD in large-scale screening efforts by capturing abnormal nocturnal movements, they require a reliable and efficient analysis pipeline. This study presents ActiTect, a fully automated, open-source machine learning tool to identify RBD from actigraphy recordings. To ensure generalizability across heterogeneous acquisition settings, our pipeline includes robust preprocessing and automated sleep-wake detection to harmonize multi-device data and extract physiologically interpretable motion features. Model development was conducted on a cohort of 78 individuals, yielding strong discrimination under nested cross-validation (AUROC = 0.95). Generalization was confirmed on a blinded local test set (n = 31, AUROC = 0.86) and two independent external cohorts (n = 113, AUROC = 0.84; n = 57, AUROC = 0.94). To assess robustness, leave-one-dataset-out cross-validation across cohorts demonstrated consistent performance (AUROC range = 0.84-0.89). Complementary stability analysis showed that predictive features remained reproducible across datasets, supporting the pooled multi-center pre-trained model for broader deployment. As an open-source, easy-to-use tool, ActiTect promotes adoption, independent validation, and collaborative improvements, thereby advancing generalizable wearable-based RBD detection.

Identifiers

PMID42286243
PMCPMC13498587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.